Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
The GLP-1 drug market appears moderately fragmented, with several key players exerting significant influence
While the research base for microdosing, specifically, is still developing, and lower-dose protocols are being explored, though clinical evidence for efficacy at sub-therapeutic doses remains limited
It is important to emphasize that the risk of eye problems appears primarily concentrated in patients with pre-existing diabetic retinopathy who experience rapid glycemic improvement
Pulse pressure is inversely correlated with arterial compliance, which is frequently impaired in patients with HFpEF, where increases in aortic stiffness contribute to elevation in cardiac filling pressures, especially during exercise 24